Advertisement

pp 1-6 | Cite as

Intraoperative Treatment with 5-FU

  • Guillermo Blugerman
  • Diego Schavelzon
  • Roberto Rodrigo Cáceres
  • Victoria Schavelzon
  • Miguel Mussi
  • Guido Blugerman
Chapter
Part of the Recent Clinical Techniques, Results, and Research in Wounds book series

Abstract

The use of 5-FU and its effectiveness in the treatment of keloid and hypertrophic scar have been evidenced in several studies reaching very favorable results. Currently, the use has been directed as therapy on healing states with poor evolution already established, where the inhibitory effect of 5-FU on fibroblastic proliferation results in the improvement of the epithelial characteristics of healing. In this work, the premise of reducing the risk of pathological scarring, in people with high probabilities, or recurrence in patients with a history of poor healing, by using gauze soaked with 5-FU applied topically for 5 min over the incisions of the surgical approach made during surgery.

We present the experience of 5 years and the results obtained with intraoperative therapy with this methodology.

References

  1. 1.
    Kose O Waseem A (2008) Keloids and hypertrophic scars: are they two different sides of the same coin? Dermatol Surg 34:336–346Google Scholar
  2. 2.
    Tayal V, Kalra BS (2008) Cytokines and anticytokines as therapeutics an update. Eur J Pharmacol 579:1–12Google Scholar
  3. 3.
    Edriss AS, Mestak J (2005) Management of keloid and hypertrophy scars. Ann Burns Fire Disasters 18(4):202–210Google Scholar
  4. 4.
    Villafuerte-Vélez CK, Castro-Cabrera AC, Restrepo-Villafuerte C (2017) Corticoterapia profiláctica transquirurgica de la hiperplasia cicatrizal. Cir Plast Iberolatinoam 43(1):33–39Google Scholar
  5. 5.
    Five-year follow-up of the Fluorouracil Filtering Surgery Study. The Fluorouracil Filtering Surgery Study Group (1993) Am J Ophthalmol 115:82–92Google Scholar
  6. 6.
    Bulstrode NW, Mudera V, McGrouther DA, Grobbelaar AO, Cambrey AD (2005) 5-fluorouracil selectively inhibits collagen synthesis. Plast Reconstr Surg 116:209–221Google Scholar
  7. 7.
    Khaw PT, Sherwood MB, MacKay SL, Rossi MJ, Schultz G (1992) Five minute treatments with fluorouracil, floxuridine, and mitomycin have long term effects on human Tenon’s capsule fibroblasts. Arch Ophthalmol 110:1150–1154Google Scholar
  8. 8.
    Fitzpatrick RE (1999) Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 25:224–232Google Scholar
  9. 9.
    Uppal RS, Khan U, Kakar S, Talas G, Chapman P, McGrouther AD (2001) The effects of a single dose of 5-fluorouracil on keloid scars. A clinical trial of timed wound irrigation after extralesional excision. Plast Reconstr Surg 108:1218–1224Google Scholar
  10. 10.
    Fatemi MJ, Shirani S, Sobhani R, Lebaschi AH, Gharegozlou MJ, Bagheri T, Pedram M, Saberi M, Araghi S, Fatemi MA (2018) Prevention of peritendinous adhesion formation after the flexor tendon surgery in rabbits. A comparative study between use of local interferon-α, interferon-β, and 5-fluorouracil. Ann Plast Surg 80(2):171–175Google Scholar
  11. 11.
    Karaaltin MV, Ozalp B, Dadaci M, Kayıkcıoglu A, Kecik A, Oner F (2012) The effects of 5-fluorouracil on flexor tendon healing by using a biodegradable gelatin, slow releasing system. Experimental study in a hen model. J Hand Surg Eur Vol 38(6):651–657Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Guillermo Blugerman
    • 1
  • Diego Schavelzon
    • 1
  • Roberto Rodrigo Cáceres
    • 1
  • Victoria Schavelzon
    • 1
  • Miguel Mussi
    • 1
  • Guido Blugerman
    • 1
  1. 1.Centro B & S Excelencia en Cirugía PlásticaBuenos AiresArgentina

Personalised recommendations